
浏览全部资源
扫码关注微信
纸质出版日期:2017
移动端阅览
卢春远, 林兴, 黄权芳, 等. 山芝麻酸甲酯对CCl致大鼠慢性肝损伤的作用及其机制的影响[J]. 中国实验方剂学杂志, 2017,23(7):141-147.
LU Chun-yuan, LIN Xing, HUANG Quan-fang, et al. Protective Effect and Mechanism of Methyl Helicteres on Chronic Liver Injury Induced by CCl in Rats[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(7): 141-147.
卢春远, 林兴, 黄权芳, 等. 山芝麻酸甲酯对CCl致大鼠慢性肝损伤的作用及其机制的影响[J]. 中国实验方剂学杂志, 2017,23(7):141-147. DOI: 10.13422/j.cnki.syfjx.2017070141.
LU Chun-yuan, LIN Xing, HUANG Quan-fang, et al. Protective Effect and Mechanism of Methyl Helicteres on Chronic Liver Injury Induced by CCl in Rats[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(7): 141-147. DOI: 10.13422/j.cnki.syfjx.2017070141.
目的:研究山芝麻酸甲酯对四氯化碳(CCl4)诱发的大鼠肝损伤的保护作用及其机制。方法:将大鼠随机分为正常组、模型组、水飞蓟素组(50 mg·kg-1)及山芝麻酸甲酯低、高剂量组(50,200 mg·kg-1)。除正常组外,其余各组大鼠灌胃给予20% CCl4,每周2次,总共8周,制备大鼠慢性损伤模型,与此同时,治疗组每日给大鼠灌胃山芝麻酸甲酯或水飞蓟素1次,共8周。实验结束后,酶联免疫吸附(ELISA)试剂盒检测血清丙氨酸氨基转移酶(ALT),天门冬氨酸氨基转移酶(AST),白蛋白(ALB)活性及血浆中白细胞介素-6(IL-6),肿瘤坏死因子-α(TNF-α)含量。肝组织苏木素-伊红(HE)染色,观察各组大鼠肝脏病变情况。酶联免疫吸附试验(ELISA)试剂盒检测肝组织超氧化物歧化酶(SOD),谷胱甘肽过氧化物酶(GSH-Px),谷胱甘肽还原酶(GSH-Rd),细胞核转录因子-κB p65(NF-κB p65)含量。蛋白免疫印迹法(Western blot)法检测肝组织中诱导型一氧化氮合酶(iNOS),环氧合酶-2(COX-2),半胱氨酸天冬氨酸特异性蛋白酶-3(Caspase-3),半胱氨酸天冬氨酸特异性蛋白酶-8(Caspase-8),以及凋亡相关蛋白Fas,FasL蛋白表达的变化。结果:山芝麻酸甲酯明显改善CCl4引起的严重病理性肝损伤;降低大鼠血清ALT,AST和ALB的水平,提高肝脏SOD,GSH-Px和GSH-Rd的活力;明显降低血浆中炎症因子IL-6和TNF-α的含量。进一步的研究发现,山芝麻酸甲酯明显抑制了与炎症反应调节相关的信号通路NF-κB,以及重要酶iNOS和COX-2的活力。此外,山芝麻酸甲酯明显抑制Caspase-3,Caspase-8,Fas和FasL蛋白的表达,减少肝细胞凋亡。结论:山芝麻酸甲酯对CCl4致大鼠肝损伤具有保护作用,其机制可能与抑制NF-κB信号通路减轻炎症反应以及减少细胞凋亡有关。
Objective: To study the protective effect and mechanism of methyl helicterate isolated from Helicteres Radix on chronic liver injury induced by carbon tetrachloride (CCl4) in rats. Method: The rats were randomly divided into 5 groups
including normal control group
model group
silymarin positive control group(50 mg·kg-1)
and high and low-dose methyl helicterate (200
50 mg·kg-1) groups. Except for the normal control group
all of the other groups were intragastrically administrated with 20% CCl4 for 8 weeks
twice a week. Meanwhile
the animals in the positive control group and methyl helicterate-treated groups were given silymarin (50 mg·kg-1) and methyl helicterate (200
50 mg·kg-1) by gavage once a day for 8 weeks. After the experiment
the levels of serum alanine aminotransferase (ALT)
aspartate aminotransferase (AST)
albumin (ALB) and plasma interleukin-6 (IL-6)
tumor necrosis factor -α (TNF-α) were detected by enzyme-linked immuno sorbent assay(ELISA) kits. The hepatic pathological changes were observed by HE staining. And the levels of superoxide dismutase (SOD)
glutathione peroxidase (GSH-Px)
glutathione reductase (GSH-Rd)
NF-κB p65 in liver tissues were detected by ELISA kits. Western blot assay was performed to detect the expression of nitric oxide synthase (iNOS)
cyclooxygenase-2 (COX-2)
Caspase-3
Caspase-8 Fas and FasL in liver tissues. Result: Methyl helicterate significantly alliviated CCl4-induced serious liver injury
decreased the levels of serum ALT
AST and ALB
while increased the activities of hepatic SOD
GSH-Px and GSH-Rd. Methyl helicterate also reduced the contents of inflammatory cytokines TNF-α and IL-6 in liver tissues. The further study showed that methyl helicterate significantly inhibited the vitality of NF-κB
iNOS and COX-2
which played a crucial role in regulat inginflammatory response.In addition
methyl helicterate significantly suppressed the expressions of Caspase-3
Caspase-8
Fas and FasL
and reduced the hepatocytes apoptosis. Conclusion: Methyl helicterate alleviates liver injury induced by CCl4 in rats
the mechanism may be associated with the inhibition of NF-κB signaling pathway and the decrease in cell apoptosis.
0
浏览量
5
下载量
5
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621